Skip to main content
logo
Genomtec S.A. (WSE:GMT)
Poland flag Poland · Delayed Price · Currency is PLN
4.700
-0.075 (-1.57%)
Apr 28, 2026, 5:03 PM CET

Genomtec Income Statement

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
0.02000.040.220.02
Revenue Growth (YoY)
1400.00%--97.50%-81.73%995.00%-
Cost of Revenue
8.134.310.793.275.383.53
Gross Profit
-8.12-4.31-0.79-3.23-5.16-3.51
Selling, General & Admin
5.539.149.438.575.3610.97
Other Operating Expenses
-2.86-2.39-1.41-0.31-3.53-3.62
Operating Expenses
2.686.768.028.261.837.36
Operating Income
-10.79-11.06-8.82-11.49-7-10.86
Interest Expense
-0.28-0.13-0.12-0.2-0.03-0.02
Interest & Investment Income
0.080.070.06--0
Currency Exchange Gain (Loss)
-0.07-0.07-0.13-0.1-0.09-0.06
Other Non Operating Income (Expenses)
-0-0-0.12-0.09--0
EBT Excluding Unusual Items
-11.07-11.2-9.12-11.88-7.11-10.94
Gain (Loss) on Sale of Assets
-0.010.08---
Asset Writedown
000---
Pretax Income
-11.06-11.19-9.03-11.88-7.11-10.94
Income Tax Expense
-0.050.02-0.020.050.010
Net Income
-11.01-11.21-9.01-11.93-7.12-10.94
Net Income to Common
-11.01-11.21-9.01-11.93-7.12-10.94
Shares Outstanding (Basic)
151312988
Shares Outstanding (Diluted)
151312988
Shares Change (YoY)
9.56%8.70%30.90%14.78%--
EPS (Basic)
-0.75-0.84-0.74-1.27-0.87-1.34
EPS (Diluted)
-0.75-0.84-0.74-1.27-0.87-1.34
Free Cash Flow
-7.92-6.78-11.48-7.93-5.71-2.63
Free Cash Flow Per Share
-0.54-0.51-0.94-0.85-0.70-0.32
Operating Margin
-71960.00%-1106400.00%-881500.00%-28730.00%-3194.06%-54315.00%
Profit Margin
-73393.33%-1120800.00%-901300.00%-29820.00%-3248.86%-54695.00%
Free Cash Flow Margin
-52780.00%-677500.00%-1147900.00%-19822.50%-2608.68%-13135.00%
EBITDA
-8.06-8.73-7.66-11.06-6.49-10.62
D&A For EBITDA
2.732.331.160.440.50.24
EBIT
-10.79-11.06-8.82-11.49-7-10.86
Source: S&P Global Market Intelligence. Standard template. Financial Sources.